Immune cell signaling in autoimmune diseases.

On September 20, 2016 the American Autoimmune Related Disease Association convened a selected group of 16 experts in Washington DC to discuss current issues and future directions of research in autoimmune diseases from the cell signaling perspective. The major topics considered included new findings on the follicular T cell cells in mice, their metabolic patterns and their control by the newly discovered T follicular regulatory cells. Current work on the metabolic pathways deemed important for the function of T cells was presented. The broader implications of these studies on our understanding of human and murine T regulatory cell and current aspects of B cell biology, innate immunity and organ damage were discussed. This document should provide the reader with a quick update on these topics and help instigate novel studies.

[1]  H. Cathro,et al.  Cgnz1 allele confers kidney resistance to damage preventing progression of immune complex–mediated acute lupus glomerulonephritis , 2013, The Journal of experimental medicine.

[2]  G. Rajagopalan,et al.  HLA-DR3 restricted T cell epitope mimicry in induction of autoimmune response to lupus-associated antigen SmD. , 2011, Journal of autoimmunity.

[3]  Hughes,et al.  Anti‐endothelial cell antibodies in systemic vasculitis and systemic lupus erythematosus (SLE): effects of heat inactivation on binding and specificity , 1999, Clinical and experimental immunology.

[4]  Jefte M. Drijvers,et al.  Clonal expansion of CD4(+) cytotoxic T lymphocytes in patients with IgG4-related disease. , 2016, The Journal of allergy and clinical immunology.

[5]  L. Suresh,et al.  Central role for marginal zone B cells in an animal model of Sjogren's syndrome. , 2016, Clinical immunology.

[6]  F. Shi,et al.  Tolerance induced by anti-DNA Ig peptide in (NZB×NZW)F1 lupus mice impinges on the resistance of effector T cells to suppression by regulatory T cells. , 2012, Clinical immunology.

[7]  Robert W. Williams,et al.  Interleukin 17–producing T helper cells and interleukin 17 orchestrate autoreactive germinal center development in autoimmune BXD2 mice , 2008, Nature Immunology.

[8]  V. Werth,et al.  Cutaneous Lupus Erythematosus: An Update on Pathogenesis, Diagnosis and Treatment , 2016, American Journal of Clinical Dermatology.

[9]  K. Leslie,et al.  Cutting Edge Issues in Goodpasture’s Disease , 2011, Clinical reviews in allergy & immunology.

[10]  K. Tung,et al.  Breaking Tolerance to Double Stranded DNA, Nucleosome, and Other Nuclear Antigens Is Not Required for the Pathogenesis of Lupus Glomerulonephritis , 2004, The Journal of experimental medicine.

[11]  Vikram Deshpande,et al.  IgG4-Related Disease , 2013, International journal of rheumatology.

[12]  L. Morel,et al.  Metabolic Factors that Contribute to Lupus Pathogenesis. , 2016, Critical reviews in immunology.

[13]  A. La Cava,et al.  Cutting Edge: Regulatory T Cells Directly Suppress B Cells in Systemic Lupus Erythematosus1 , 2009, The Journal of Immunology.

[14]  Gerald McGwin,et al.  Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. , 2012, Arthritis and rheumatism.

[15]  S. Faraone,et al.  Mechanistic Target of Rapamycin Activation Triggers IL-4 Production and Necrotic Death of Double-Negative T Cells in Patients with Systemic Lupus Erythematosus , 2013, The Journal of Immunology.

[16]  T. Malek,et al.  Promoting Immune Regulation in Type 1 Diabetes Using Low-Dose Interleukin-2 , 2016, Current Diabetes Reports.

[17]  G. Tsokos,et al.  KN-93, an inhibitor of calcium/calmodulin-dependent protein kinase IV, promotes generation and function of Foxp3+ regulatory T cells in MRL/lpr mice , 2014, Autoimmunity.

[18]  S. Sakaguchi.  Naturally arising CD4+ regulatory t cells for immunologic self-tolerance and negative control of immune responses. , 2004, Annual review of immunology.

[19]  A. La Cava,et al.  Leptin promotes systemic lupus erythematosus by increasing autoantibody production and inhibiting immune regulation , 2016, Proceedings of the National Academy of Sciences.

[20]  A. La Cava,et al.  Cutting Edge: Fasting-Induced Hypoleptinemia Expands Functional Regulatory T Cells in Systemic Lupus Erythematosus , 2012, The Journal of Immunology.

[21]  E. Latz,et al.  TLR9 Deficiency Leads to Accelerated Renal Disease and Myeloid Lineage Abnormalities in Pristane-Induced Murine Lupus , 2016, The Journal of Immunology.

[22]  Stevens Dl,et al.  Post-Streptococcal Glomerulonephritis -- Streptococcus pyogenes: Basic Biology to Clinical Manifestations , 2016 .

[23]  G. Palade,et al.  PV-1 is a component of the fenestral and stomatal diaphragms in fenestrated endothelia. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[24]  L. Adams,et al.  Rapamycin prolongs survival and arrests pathophysiologic changes in murine systemic lupus erythematosus. , 1994, Arthritis and rheumatism.

[25]  L. Suresh,et al.  Different Stages of Primary Sjögren’s Syndrome Involving Lymphotoxin and Type 1 IFN , 2013, The Journal of Immunology.

[26]  Joseph Mendola,et al.  From the Good , 2014 .

[27]  Takahisa Suzuki,et al.  Lupus Nephritis IgG Induction of Calcium/Calmodulin‐Dependent Protein Kinase IV Expression in Podocytes and Alteration of Their Function , 2015, Arthritis & rheumatology.

[28]  Marco Pahor,et al.  Rapamycin fed late in life extends lifespan in genetically heterogeneous mice , 2009, Nature.

[29]  G. Tsokos,et al.  Programmed Cell Death 1 and Helios Distinguish TCR-αβ+ Double-Negative (CD4−CD8−) T Cells That Derive from Self-Reactive CD8 T Cells , 2015, The Journal of Immunology.

[30]  G. Bhagat,et al.  Phosphorylation of IRF4 by ROCK2 regulates IL-17 and IL-21 production and the development of autoimmunity in mice. , 2010, The Journal of clinical investigation.

[31]  L. Morel.  Immunometabolism in systemic lupus erythematosus , 2017, Nature Reviews Rheumatology.

[32]  Jing Wu,et al.  A Role for Lymphotoxin in Primary Sjögren’s Disease , 2010, The Journal of Immunology.

[33]  J. Weiss,et al.  Selective oral ROCK2 inhibitor down-regulates IL-21 and IL-17 secretion in human T cells via STAT3-dependent mechanism , 2014, Proceedings of the National Academy of Sciences.

[34]  Wei Chen,et al.  Cutting Edge: Selective Oral ROCK2 Inhibitor Reduces Clinical Scores in Patients with Psoriasis Vulgaris and Normalizes Skin Pathology via Concurrent Regulation of IL-17 and IL-10 , 2017, The Journal of Immunology.

[35]  A. Perl,et al.  Rapamycin reduces disease activity and normalizes T cell activation-induced calcium fluxing in patients with systemic lupus erythematosus. , 2006, Arthritis and rheumatism.

[36]  A. Sharpe,et al.  T follicular regulatory cells , 2016, Immunological reviews.

[37]  P. Debré,et al.  Global Natural Regulatory T Cell Depletion in Active Systemic Lupus Erythematosus1 , 2005, The Journal of Immunology.

[38]  T. Rauen,et al.  cAMP-responsive Element Modulator α (CREMα) trans-Represses the Transmembrane Glycoprotein CD8 and Contributes to the Generation of CD3+CD4−CD8− T Cells in Health and Disease* , 2013, The Journal of Biological Chemistry.

[39]  G. Canaud,et al.  Inhibition of the mTORC pathway in the antiphospholipid syndrome. , 2014, The New England journal of medicine.

[40]  Carolyne Smith,et al.  The role of neutrophils in the pathogenesis of systemic lupus erythematosus , 2015, Current opinion in rheumatology.

[41]  T. Malek,et al.  The IL-2/IL-2R system: from basic science to therapeutic applications to enhance immune regulation , 2013, Immunologic Research.

[42]  T. Rauen,et al.  CaMK4-dependent activation of AKT/mTOR and CREM-α underlies autoimmunity-associated Th17 imbalance. , 2014, The Journal of clinical investigation.

[43]  A. Perl.  Activation of mTOR (mechanistic target of rapamycin) in rheumatic diseases , 2016, Nature Reviews Rheumatology.

[44]  Linjiang Zhu,et al.  A low interleukin-2 receptor signaling threshold supports the development and homeostasis of T regulatory cells. , 2009, Immunity.

[45]  T. Fahmy,et al.  Cutting Edge: Nanogel-Based Delivery of an Inhibitor of CaMK4 to CD4+ T Cells Suppresses Experimental Autoimmune Encephalomyelitis and Lupus-like Disease in Mice , 2015, The Journal of Immunology.

[46]  J. Shupe,et al.  TLR9 Regulates TLR7- and MyD88-Dependent Autoantibody Production and Disease in a Murine Model of Lupus , 2010, The Journal of Immunology.

[47]  J. O’Shea,et al.  Celastrol, a Chinese herbal compound, controls autoimmune inflammation by altering the balance of pathogenic and regulatory T cells in the target organ , 2015, Clinical immunology.

[48]  T. Rauen,et al.  Cutting Edge: Calcium/Calmodulin-Dependent Protein Kinase Type IV Is Essential for Mesangial Cell Proliferation and Lupus Nephritis , 2011, The Journal of Immunology.

[49]  Agnieszka Szymula,et al.  T cell epitope mimicry between Sjögren's syndrome Antigen A (SSA)/Ro60 and oral, gut, skin and vaginal bacteria. , 2014, Clinical immunology.

[50]  G. Cattoretti,et al.  Molecular cloning of IBP, a SWAP-70 homologous GEF, which is highly expressed in the immune system. , 2003, Human immunology.

[51]  S. Tangye,et al.  The good, the bad and the ugly — TFH cells in human health and disease , 2013, Nature Reviews Immunology.

[52]  P. Cohen,et al.  Disturbances of apoptotic cell clearance in systemic lupus erythematosus , 2011, Arthritis research & therapy.

[53]  J. Asara,et al.  Comprehensive metabolome analyses reveal N-acetylcysteine-responsive accumulation of kynurenine in systemic lupus erythematosus: implications for activation of the mechanistic target of rapamycin , 2015, Metabolomics.

[54]  A. Perl,et al.  Mechanistic Target of Rapamycin Complex 1 Expands Th17 and IL-4+ CD4−CD8− Double-Negative T Cells and Contracts Regulatory T Cells in Systemic Lupus Erythematosus , 2014, The Journal of Immunology.

[55]  G. Tsokos,et al.  T cell receptor alpha/beta expressing double-negative (CD4-/CD8-) and CD4+ T helper cells in humans augment the production of pathogenic anti-DNA autoantibodies associated with lupus nephritis. , 1989, Journal of immunology.

[56]  O. Pankewycz,et al.  IL-14 alpha, the nexus for primary Sjögren's disease in mice and humans. , 2009, Clinical immunology.

[57]  H. Hsu,et al.  Interleukin‐21 Promotes Germinal Center Reaction by Skewing the Follicular Regulatory T Cell to Follicular Helper T Cell Balance in Autoimmune BXD2 Mice , 2014, Arthritis & rheumatology.

[58]  J F Fries,et al.  The 1982 revised criteria for the classification of systemic lupus erythematosus. , 1982, Arthritis and rheumatism.

[59]  Nicolas Chevrier,et al.  Suppression by TFR cells leads to durable and selective inhibition of B cell effector function , 2016, Nature Immunology.

[60]  Loise M. Francisco,et al.  The receptor PD-1 controls follicular regulatory T cells in the lymph nodes and blood , 2012, Nature Immunology.

[61]  T. Kurosaki,et al.  Regulatory T cells control antigen-specific expansion of Tfh cell number and humoral immune responses via the coreceptor CTLA-4. , 2014, Immunity.

[62]  J. Bluestone,et al.  Suppression of Disease in New Zealand Black/New Zealand White Lupus-Prone Mice by Adoptive Transfer of Ex Vivo Expanded Regulatory T Cells1 , 2006, The Journal of Immunology.

[63]  T. Mayadas,et al.  Mechanisms of Immune Complex–Mediated Neutrophil Recruitment and Tissue Injury , 2009, Circulation.

[64]  A. Zanin-Zhorov,et al.  ROCKing cytokine secretion balance in human T cells. , 2015, Cytokine.

[65]  A. La Cava,et al.  Anti-DNA Ig peptides promote Treg cell activity in systemic lupus erythematosus patients. , 2008, Arthritis and rheumatism.

[66]  F. Middleton,et al.  HRES-1/Rab4-mediated depletion of Drp1 impairs mitochondrial homeostasis and represents a target for treatment in SLE , 2013, Annals of the rheumatic diseases.

[67]  T. Malek,et al.  Interleukin-2 receptor signaling: at the interface between tolerance and immunity. , 2010, Immunity.

[68]  J. McCluskey,et al.  Pro‐inflammatory self‐reactive T cells are found within murine TCR‐αβ+CD4−CD8−PD‐1+ cells , 2016, European journal of immunology.

[69]  C. Rozo,et al.  Targeting the RhoA-ROCK pathway to reverse T-cell dysfunction in SLE , 2016, Annals of the rheumatic diseases.

[70]  Qinzhong Chen,et al.  Loss of IRF-4-binding protein leads to the spontaneous development of systemic autoimmunity. , 2006, The Journal of clinical investigation.

[71]  M. Oukka,et al.  Expanded Double Negative T Cells in Patients with Systemic Lupus Erythematosus Produce IL-17 and Infiltrate the Kidneys1 , 2008, The Journal of Immunology.

[72]  P. Worley,et al.  The mTOR kinase differentially regulates effector and regulatory T cell lineage commitment. , 2009, Immunity.

[73]  A. La Cava,et al.  Ig-Reactive CD4+CD25+ T Cells from Tolerized (New Zealand Black × New Zealand White)F1 Mice Suppress In Vitro Production of Antibodies to DNA1 , 2004, The Journal of Immunology.

[74]  K. Tung,et al.  Phosphorylated ERM Is Responsible for Increased T Cell Polarization, Adhesion, and Migration in Patients with Systemic Lupus Erythematosus12 , 2007, The Journal of Immunology.

[75]  G. Tsokos,et al.  Engagement of SLAMF3 enhances CD4+ T-cell sensitivity to IL-2 and favors regulatory T-cell polarization in systemic lupus erythematosus , 2016, Proceedings of the National Academy of Sciences.

[76]  K. Druey,et al.  Extension of the germinal center stage of B cell development promotes autoantibodies in BXD2 mice. , 2013, Arthritis and rheumatism.

[77]  Hee-Kap Kang,et al.  Very Low-Dose Tolerance with Nucleosomal Peptides Controls Lupus and Induces Potent Regulatory T Cell Subsets12 , 2005, The Journal of Immunology.

[78]  Miss A.O. Penney.  (b) , 1974, The New Yale Book of Quotations.

[79]  F. Shi,et al.  Protection against renal disease in (NZB x NZW)F(1) lupus-prone mice after somatic B cell gene vaccination with anti-DNA immunoglobulin consensus peptide. , 2007, Arthritis and rheumatism.

[80]  M. Hochberg,et al.  Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. , 1997, Arthritis and rheumatism.

[81]  A. Quinlan,et al.  Genetics of systemic lupus erythematosus: immune responses and end organ resistance to damage. , 2014, Current opinion in immunology.

[82]  C. Alpers,et al.  Opposing Impact of B Cell–Intrinsic TLR7 and TLR9 Signals on Autoantibody Repertoire and Systemic Inflammation , 2014, The Journal of Immunology.

[83]  Stephen V Faraone,et al.  N-acetylcysteine reduces disease activity by blocking mammalian target of rapamycin in T cells from systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial. , 2012, Arthritis and rheumatism.

[84]  L. Ng,et al.  Development of nephritis but not sialadenitis in autoimmune‐prone BAFF transgenic mice lacking marginal zone B cells , 2006, European journal of immunology.

[85]  G. Tsokos,et al.  Calcium/Calmodulin-Dependent Protein Kinase IV Suppresses IL-2 Production and Regulatory T Cell Activity in Lupus , 2012, The Journal of Immunology.

[86]  J. Cowell,et al.  Development of Autoimmunity in IL-14α-Transgenic Mice1 , 2006, The Journal of Immunology.

[87]  B. Diamond,et al.  Human Double-Negative T Cells in Systemic Lupus Erythematosus Provide Help for IgG and Are Restricted by CD1c1 , 2000, The Journal of Immunology.

[88]  G. Tsokos,et al.  Systemic lupus erythematosus. , 2011, The New England journal of medicine.

[89]  B. Berman,et al.  Traditional Chinese medicine: potential for clinical treatment of rheumatoid arthritis , 2014, Expert review of clinical immunology.

[90]  Victor L. J. Tybulewicz,et al.  Rho family GTPases and their regulators in lymphocytes , 2009, Nature Reviews Immunology.

[91]  K. Moudgil,et al.  Celastrus-derived Celastrol Suppresses Autoimmune Arthritis by Modulating Antigen-induced Cellular and Humoral Effector Responses* , 2011, The Journal of Biological Chemistry.

[92]  J. Weiss,et al.  Targeted Rho-associated kinase 2 inhibition suppresses murine and human chronic GVHD through a Stat3-dependent mechanism. , 2016, Blood.

[93]  B. Croker,et al.  Normalization of CD4+ T cell metabolism reverses lupus , 2015, Science Translational Medicine.

[94]  O. Florey,et al.  Antiendothelial cell antibodies mediate enhanced leukocyte adhesion to cytokine-activated endothelial cells through a novel mechanism requiring cooperation between Fc{gamma}RIIa and CXCR1/2. , 2007, Blood.

[95]  R. Falk,et al.  Pathogenesis of antineutrophil cytoplasmic autoantibody-mediated disease , 2014, Nature Reviews Rheumatology.

[96]  T. Mayadas,et al.  Fc gamma RIII mediates neutrophil recruitment to immune complexes. a mechanism for neutrophil accumulation in immune-mediated inflammation. , 2001, Immunity.

[97]  G. Tsokos,et al.  Suppression of autoimmunity and organ pathology in lupus-prone mice upon inhibition of calcium/calmodulin-dependent protein kinase type IV. , 2011, Arthritis and rheumatism.

[98]  A. Sharpe,et al.  The coinhibitory receptor CTLA-4 controls B cell responses by modulating T follicular helper, T follicular regulatory, and T regulatory cells. , 2014, Immunity.

[99]  S. Landas,et al.  Mitochondrial Dysfunction in the Liver and Antiphospholipid Antibody Production Precede Disease Onset and Respond to Rapamycin in Lupus‐Prone Mice , 2016, Arthritis & rheumatology.

[100]  Amy Donate,et al.  The value of animal models to study immunopathology of primary human Sjögren's syndrome symptoms , 2014, Expert review of clinical immunology.

[101]  F. Shi,et al.  Regulatory CD4+ T Cells Promote B Cell Anergy in Murine Lupus , 2014, The Journal of Immunology.

[102]  A. Sharpe,et al.  T follicular regulatory cells in the regulation of B cell responses. , 2015, Trends in immunology.

[103]  G. G. Stokes.  "J." , 1890, The New Yale Book of Quotations.

[104]  J. Weiss,et al.  ROCK2 signaling is required to induce a subset of T follicular helper cells through opposing effects on STATs in autoimmune settings , 2016, Science Signaling.

[105]  R. Jessberger,et al.  SWEF Proteins Distinctly Control Maintenance and Differentiation of Hematopoietic Stem Cells , 2016, PloS one.

[106]  J. Stone,et al.  De novo oligoclonal expansions of circulating plasmablasts in active and relapsing IgG4-related disease. , 2014, The Journal of allergy and clinical immunology.

[107]  C. Mawrin,et al.  Systemic lupus erythematosus serum IgG increases CREM binding to the IL-2 promoter and suppresses IL-2 production through CaMKIV. , 2005, The Journal of clinical investigation.

[108]  G. Tsokos,et al.  Calcium/Calmodulin‐Dependent Kinase IV Facilitates the Recruitment of Interleukin‐17–Producing Cells to Target Organs Through the CCR6/CCL20 Axis in Th17 Cell–Driven Inflammatory Diseases , 2016, Arthritis & rheumatology.

[109]  F. Middleton,et al.  Activation of Mammalian Target of Rapamycin Controls the Loss of TCRζ in Lupus T Cells through HRES-1/Rab4-Regulated Lysosomal Degradation1 , 2009, The Journal of Immunology.

[110]  K. Druey,et al.  IL-17RA Is Essential for Optimal Localization of Follicular Th Cells in the Germinal Center Light Zone To Promote Autoantibody-Producing B Cells , 2013, The Journal of Immunology.

[111]  J. Stains,et al.  Celastrus and Its Bioactive Celastrol Protect against Bone Damage in Autoimmune Arthritis by Modulating Osteoimmune Cross-talk* , 2012, The Journal of Biological Chemistry.

[112]  D. Klatzmann,et al.  Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients. , 2015, Journal of autoimmunity.

[113]  M. Nussenzweig,et al.  Dopamine in germinal centers , 2017, Nature Immunology.

[114]  G. Tsokos,et al.  Human TCR-αβ+ CD4− CD8− T Cells Can Derive from CD8+ T Cells and Display an Inflammatory Effector Phenotype1 , 2009, The Journal of Immunology.

[115]  R. Jessberger,et al.  Dual regulation of IRF4 function in T and B cells is required for the coordination of T–B cell interactions and the prevention of autoimmunity , 2012, The Journal of experimental medicine.

[116]  D. Isenberg,et al.  Characterization of CD3+CD4-CD8- (double negative) T cells in patients with systemic lupus erythematosus: activation markers , 2002, Lupus.

[117]  K. Tung,et al.  NZM2328: a new mouse model of systemic lupus erythematosus with unique genetic susceptibility loci. , 2001, Clinical immunology.

[118]  D. Klatzmann,et al.  Selective IL-2 Responsiveness of Regulatory T Cells Through Multiple Intrinsic Mechanisms Supports the Use of Low-Dose IL-2 Therapy in Type 1 Diabetes , 2015, Diabetes.